Teladoc Health (NYSE:TDOC) Price Target Lowered to $8.00 at Jefferies Financial Group

Teladoc Health (NYSE:TDOC - Free Report) had its price objective trimmed by Jefferies Financial Group from $10.00 to $8.00 in a research note published on Monday,Benzinga reports. The brokerage currently has a hold rating on the health services provider's stock.

A number of other analysts also recently weighed in on the stock. Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a report on Thursday, February 27th. Oppenheimer cut their target price on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a research note on Friday, January 24th. Bank of America decreased their price target on Teladoc Health from $9.50 to $8.00 and set a "neutral" rating on the stock in a research note on Friday, April 11th. Royal Bank of Canada upped their price objective on Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Finally, The Goldman Sachs Group decreased their target price on Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a research report on Monday, March 3rd. Twelve research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat, Teladoc Health currently has a consensus rating of "Hold" and an average price target of $10.71.

Teladoc Health Stock Performance

TDOC stock traded down $0.07 on Monday, reaching $7.19. 2,388,172 shares of the company were exchanged, compared to its average volume of 6,219,271. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. Teladoc Health has a 12 month low of $6.35 and a 12 month high of $15.21. The stock's fifty day moving average price is $8.52 and its 200 day moving average price is $9.57. The firm has a market capitalization of $1.26 billion, a PE ratio of -1.25 and a beta of 1.73.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. On average, research analysts anticipate that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insider Transactions at Teladoc Health

In related news, insider Adam C. Vandervoort sold 11,011 shares of the company's stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now owns 64,308 shares in the company, valued at approximately $541,473.36. This represents a 14.62 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.58% of the company's stock.

Hedge Funds Weigh In On Teladoc Health

Several institutional investors and hedge funds have recently bought and sold shares of TDOC. Vanguard Group Inc. raised its position in shares of Teladoc Health by 5.9% during the 4th quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock valued at $167,830,000 after purchasing an additional 1,029,829 shares during the period. Point72 Asset Management L.P. increased its stake in Teladoc Health by 33.6% in the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock worth $101,625,000 after buying an additional 2,813,568 shares in the last quarter. Renaissance Technologies LLC raised its holdings in Teladoc Health by 15.5% during the fourth quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider's stock valued at $51,582,000 after acquiring an additional 763,265 shares during the period. Geode Capital Management LLC lifted its position in shares of Teladoc Health by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock valued at $35,894,000 after acquiring an additional 22,664 shares in the last quarter. Finally, Maple Rock Capital Partners Inc. boosted its stake in shares of Teladoc Health by 189.5% in the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock worth $32,369,000 after acquiring an additional 2,331,000 shares during the period. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.